As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Articles
-
-
Suicide ideation, attempt, and determinants among medical students Northwest Ethiopia: an institution-based cross-sectional study
-
The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review
-
The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey
The Correction to this article has been published in Annals of General Psychiatry 2020 19:45
-
Prevalence of perinatal depression among Japanese women: a meta-analysis
-
A cross-sectional analysis of video games and attention deficit hyperactivity disorder symptoms in adolescents
-
Guidelines for rating Global Assessment of Functioning (GAF)
-
Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges
-
The effects of probiotics on depressive symptoms in humans: a systematic review
The Erratum to this article has been published in Annals of General Psychiatry 2017 16:18
-
Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
Aims and scope
Annals of General Psychiatry considers manuscripts on all aspects of psychiatry, including neuroscience and psychological medicine. Both basic and clinical neuroscience contributions are encouraged.
Annals of General Psychiatry emphasizes a biopsychosocial approach to illness and health and strongly supports and follows the principles of evidence-based medicine. As an open access journal, Annals of General Psychiatry facilitates the worldwide distribution of high quality psychiatry and mental health research. The journal considers submissions on a wide range of topics including, but not limited to, psychopharmacology, forensic psychiatry, psychotic disorders, psychiatric genetics, and mood and anxiety disorders.
Featured article: Dietary total antioxidant capacity is inversely associated with depression, anxiety and some oxidative stress biomarkers in postmenopausal women
"Postmenopausal women are at higher risk of mental disorders. Oxidative stress has implication in the development of these disorders... An inverse relationship was found between dietary total antioxidant capacity (DTAC) with depression, anxiety scores and some oxidative stress biomarkers in postmenopausal women. These findings indicate DTAC may be used for developing effective dietary measures for reducing depression and anxiety in these women."
Affiliated with
-
Official publication of the International Society of Neurobiology and Psychopharmacology.
Annual Journal Metrics
-
Speed
123 days to first decision for reviewed manuscripts only
85 days to first decision for all manuscripts
238 days from submission to acceptance
12 days from acceptance to publicationCitation Impact
2.157 - 2-year Impact Factor
2.222 - 5-year Impact Factor
0.964 - Source Normalized Impact per Paper (SNIP)
0.813 - SCImago Journal Rank (SJR)Usage
457,834 Downloads
115 Altmetric mentions
